Metformin mediates MicroRNA-21 regulated circulating matrix metalloproteinase-9 in diabetic nephropathy: an in-silico and clinical study,Archives of Physiology and Biochemistry

当前位置： X-MOL 学术 › Arch. Physiol. Biochem. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Metformin mediates MicroRNA-21 regulated circulating matrix metalloproteinase-9 in diabetic nephropathy: an in-silico and clinical study
Archives of Physiology and Biochemistry ( IF 3 ) Pub Date : 2021-06-04 , DOI: 10.1080/13813455.2021.1922457
Manoj Khokhar ₁ , Dipayan Roy ₁ , Nitin Kumar Bajpai ₂ , Gopal Krishna Bohra ₃ , Dharamveer Yadav ₁ , Praveen Sharma ₁ , Purvi Purohit ₁

Affiliation

Metformin is commonly used as an oral hypoglycaemic agent in type 2 diabetes mellitus (T2DM). MicroRNA-21 is widely studied in diabetic and diabetic nephropathy (DN) patients. Matrix metalloprotein...

中文翻译：